Nevertheless, further studies were validated not only because there were indications that a subset of patients with moderately severe COPD might have benefitted by oxygen supplementation but also ...
Please provide your email address to receive an email when new articles are posted on . Mortality occurred in more patients with severe vs. mild COPD exacerbation based on Rome severity classification ...
Please provide your email address to receive an email when new articles are posted on . This analysis examined three phenotypes of pulmonary hypertension (PH) associated with COPD. Patients with ...
Adults with exacerbations of chronic obstructive pulmonary disease (ECOPD) whose condition was classified as severe using the Rome criteria had a higher risk of death at 1 year than those who were ...
Compared with placebo, the time to first moderate or severe exacerbation was longer with mepolizumab. HealthDay News — For patients with chronic obstructive pulmonary disease (COPD) with a history of ...
A new device was able to distinguish between mild and very severe chronic obstructive pulmonary disease (COPD). The “hallmark feature” of COPD is a sustained reduction of expiratory airflow, which is ...
The GOLD 2023 and 2024 reports recommend that health professionals consider triple therapy (TT) entailing combined use of a long-acting β 2 agonist (LABA), a long-acting muscarinic antagonist (LAMA), ...
The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease (COPD), Sanofi and Regeneron announced on Friday. An injectable interleukin ...
People with chronic obstructive pulmonary disease (COPD) often need to use many different inhalers every day to help them breathe better. But now, there are newer inhalers that combine different ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results